Molecular Profiles has added new manufacturing capabilities to its service offering, enabling the company to handle larger projects for pharmaceutical clients from preformulation through to phase IIa.
This capability will initially focus on the company's expert area of difficult-to-formulate molecules and enable it to offer a greater range of services to its customers.
Built within the existing site at Nottingham, UK, the new manufacturing facilities allow Molecular Profiles to provide a complete range of services including formulation development, preformulation, polymorph screening, salt selection, analytical services and clinical trial manufacturing up to phase IIa .
This decreases the need to perform a technical transfer of work to other companies and therefore lessens the risk to the customer's research.
Molecular Profiles will be discussing its manufacturing capabilities at Informex 2011 on booth #2283, taking place 7-10 February, 2011 in Charlotte, North Carolina, US.
